Isolated hepatic perfusion with oxaliplatin combined with 100 mg melphalan in patients with metastases confined to the liver: A phase I study

Iersel, L.B.J. van; Leede, E.M. de; Vahrmeijer, A.L.; Tijl, F.G.J.; Hartigh, J. den; Kuppen, P.J.K.; ... ; Velde, C.J.H. van de (2014)

Article / Letter to editor

• Isolated hepatic perfusion
• Liver metastases
• Melphalan
• Oxaliplatin
• Colorectal cancer
• Uveal melanoma

• All authors: Iersel, L.B.J. van; Leede, E.M. de; Vahrmeijer, A.L.; Tijl, F.G.J.; Hartigh, J. den; Kuppen, P.J.K.; Hartgrink, H.H.; Gelderblom, H.; Nortier, J.W.R.; Tollenaar, R.A.E.M.; Velde, C.J.H. van de
• Date: 2014-11-30
• Journal: EJSO - European Journal of Surgical Oncology
• Volume: 40
• Issue: 11
• Pages: 1557 - 1563
• DOI: doi:10.1016/j.ejso.2014.06.010